Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases

Perit Dial Int. 2014 May;34(3):317-21. doi: 10.3747/pdi.2012.00198. Epub 2013 Dec 1.

Abstract

Peritonitis is still known as an important complication of continuous ambulatory peritoneal dialysis (CAPD). Multi-drug resistant (MDR) Acinetobacter baumannii is an increasing problem worldwide. Moreover, the increasing reports of carbapenem-resistant A. baumannii strains is common. Although peritoneal dialysis-related peritonitis with MDR A. baumannii is rarely reported, infection with this organism always results in serious peritonitis and increases the possibility of dropout or mortality. Here, we present 7 cases of peritonitis caused by A. baumannii species. Among those 7 cases, 2 involved MDR A. baumannii, and 1 involved a carbapenem-resistant strain. All the MDR bacterial infections failed treatment. We also review the literature about Acinetobacter peritonitis and current treatment protocols.

Keywords: Acinetobacter baumannii; Peritonitis; multi-drug resistance; peritonitis treatment.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / etiology*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / isolation & purification*
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis / adverse effects*
  • Peritonitis / drug therapy
  • Peritonitis / etiology*
  • Peritonitis / microbiology

Substances

  • Anti-Bacterial Agents